Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice
- 1 July 2000
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 119 (1), 119-128
- https://doi.org/10.1053/gast.2000.9114
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesisEuropean Journal of Immunology, 1999
- THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and GlycolipidsAnnual Review of Immunology, 1999
- Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cellsHuman Immunology, 1999
- CD161 (NKR-P1A) Costimulation of CD1d-dependent Activation of Human T Cells Expressing Invariant Vα24JαQ T Cell Receptor α ChainsThe Journal of Experimental Medicine, 1998
- Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazineAlimentary Pharmacology & Therapeutics, 1998
- CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by GlycosylceramidesScience, 1997
- MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and FunctionAnnual Review of Immunology, 1997
- Role of NK1.1 + T Cells in a T H 2 Response and in Immunoglobulin E ProductionScience, 1995
- Structure and Function of the CD1 Family of MHC‐like Cell Surface ProteinsImmunological Reviews, 1995
- Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice.The Journal of Experimental Medicine, 1994